2026 Global: Blood Bags Market -Competitive Review (2032) report
Description
The 2026 Global: Blood Bags Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for blood bags market by geography and historical trend. The scope of the report extends to sizing of the blood bags market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Terumo Corporation, Fresenius SE & Co. KGaA, Grifols S.A., Haemonetics Corporation, Maco Pharma (Maco Pharma International GmbH), HLL Lifecare Limited, Poly Medicure Limited, Kawasumi Laboratories Inc., Weigao Group (Shandong Weigao Group Medical Polymer Co., Ltd.), and JMS Co., Ltd. are widely recognized as major companies in the blood bags market based on industry reports and market analyses. These firms lead through complementary strengths: Terumo and Fresenius emphasize technology and material innovation such as pathogen-reduction integration and DEHP-free formulations that address regulatory and safety concerns; Grifols and Haemonetics combine product breadth with global distribution networks and strategic acquisitions to extend filtration and whole-blood portfolios; Maco Pharma is known for robust European filtration and component-separation products while Kawasumi and JMS supply specialized tubing, connector technology and clinically validated bag systems widely used in Asia and export markets.
Market positioning and recent strategic moves clarify competitive dynamics among these ten players. Terumo has advanced integrated systems that speed component processing and gained regulatory approvals for pathogen-reduction technologies, strengthening hospital procurement appeal. Fresenius focuses on material science and large-scale manufacturing of DEHP-free options to meet evolving guidance on plasticizers. Grifols leverages its transfusion-business scale and product integration to supply leukoreduction and therapy-specific bags. Haemonetics has expanded via acquisitions to broaden its hospital and filtration offerings, while Maco Pharma emphasizes high-reliability filtration bags and regional service. HLL Lifecare, Poly Medicure, Weigao and JMS compete primarily on cost-competitive manufacturing, regional penetration in high-volume APAC markets, and product ranges that include single- through multi-compartment sets suitable for component therapy and blood-bank workflows. Kawasumi’s niche in precision connectors and clinically validated disposables supports transfusion safety across Japan and export markets.
Product innovation, regulatory trends and regional demand patterns shape how these companies differentiate and grow. Hospitals and blood centers increasingly prefer multi-compartment bags, integrated leukofilters, traceability-enabled packaging and non-DEHP materials, creating opportunities for technology leaders like Terumo and Fresenius while sustaining demand for high-volume suppliers such as Poly Medicure and Weigao in emerging markets. Consolidation and partnerships—illustrated by recent acquisitions and supplier collaborations—are broadening portfolios and supply security, favoring firms with integrated filtration-to-bag capabilities or global distribution networks. Price sensitivity in lower-income regions keeps market entry feasible for cost-focused manufacturers, whereas stringent regulatory environments in Europe and North America reward firms that invest in material safety, pathogen reduction, and traceability features.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for blood bags market by geography and historical trend. The scope of the report extends to sizing of the blood bags market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Terumo Corporation, Fresenius SE & Co. KGaA, Grifols S.A., Haemonetics Corporation, Maco Pharma (Maco Pharma International GmbH), HLL Lifecare Limited, Poly Medicure Limited, Kawasumi Laboratories Inc., Weigao Group (Shandong Weigao Group Medical Polymer Co., Ltd.), and JMS Co., Ltd. are widely recognized as major companies in the blood bags market based on industry reports and market analyses. These firms lead through complementary strengths: Terumo and Fresenius emphasize technology and material innovation such as pathogen-reduction integration and DEHP-free formulations that address regulatory and safety concerns; Grifols and Haemonetics combine product breadth with global distribution networks and strategic acquisitions to extend filtration and whole-blood portfolios; Maco Pharma is known for robust European filtration and component-separation products while Kawasumi and JMS supply specialized tubing, connector technology and clinically validated bag systems widely used in Asia and export markets.
Market positioning and recent strategic moves clarify competitive dynamics among these ten players. Terumo has advanced integrated systems that speed component processing and gained regulatory approvals for pathogen-reduction technologies, strengthening hospital procurement appeal. Fresenius focuses on material science and large-scale manufacturing of DEHP-free options to meet evolving guidance on plasticizers. Grifols leverages its transfusion-business scale and product integration to supply leukoreduction and therapy-specific bags. Haemonetics has expanded via acquisitions to broaden its hospital and filtration offerings, while Maco Pharma emphasizes high-reliability filtration bags and regional service. HLL Lifecare, Poly Medicure, Weigao and JMS compete primarily on cost-competitive manufacturing, regional penetration in high-volume APAC markets, and product ranges that include single- through multi-compartment sets suitable for component therapy and blood-bank workflows. Kawasumi’s niche in precision connectors and clinically validated disposables supports transfusion safety across Japan and export markets.
Product innovation, regulatory trends and regional demand patterns shape how these companies differentiate and grow. Hospitals and blood centers increasingly prefer multi-compartment bags, integrated leukofilters, traceability-enabled packaging and non-DEHP materials, creating opportunities for technology leaders like Terumo and Fresenius while sustaining demand for high-volume suppliers such as Poly Medicure and Weigao in emerging markets. Consolidation and partnerships—illustrated by recent acquisitions and supplier collaborations—are broadening portfolios and supply security, favoring firms with integrated filtration-to-bag capabilities or global distribution networks. Price sensitivity in lower-income regions keeps market entry feasible for cost-focused manufacturers, whereas stringent regulatory environments in Europe and North America reward firms that invest in material safety, pathogen reduction, and traceability features.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
